Skip to main content
Caplight Logo









Nanogen Pharmaceutical Biotechnology JSC

Nanogen Pharmaceutical Biotechnology JSC

Private
Ho Chi Minh CityHealthcare & Life Scienceshttps://nanogenpharma.com

Last Round

Private Equity

Mar 29, 2019

Est. Valuation

$220M

Total Funding Raised

$20.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nanogen Pharmaceutical Biotechnology JSC is a Vietnamese biotechnology company that researches, develops, and manufactures active pharmaceutical ingredients (APIs) and biopharmaceutical products for treating conditions like cancer, hepatitis, and anemia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biopharmaceuticalsbiosimilarsActive Pharmaceutical IngredientsAPI manufacturingrecombinant DNA technologyContract Manufacturing OrganizationCMOContract Development and Manufacturing OrganizationCDMOpharmaceutical manufacturingGMP manufacturingoncology therapeuticsCOVID-19 vaccineVietnamese biotechbiologic drugs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Book a demo to explore historical pricing and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Book a demo

For institutional investors. Book with your work email.

Nanogen Pharmaceutical Biotechnology JSC Comparables

Compare Nanogen Pharmaceutical Biotechnology JSC with similar companies based on industry and business-model similarity.

Nanogen Pharmaceutical Biotechnology JSC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biosidus
79%
Laboratorios Sanfer
79%
Polpharma Biologics
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nanogen Pharmaceutical Biotechnology JSC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMar 29, 2019
Private PlacementDec 10, 2018
Book a demo to see all 2 rounds

For institutional investors. Book with your work email.

Nanogen Pharmaceutical Biotechnology JSC Investors

Notable investors and investment history

Nanogen Pharmaceutical Biotechnology JSC investors
InvestorRounds
KIS Vietnam Securities CorporationPrivate Equity
Company K PartnersPrivate Equity
HB InvestmentPrivate Equity
Kiwoom InvestmentPrivate Equity
STIC InvestmentsPrivate Equity
Book a demo to see all investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 33, 11x the trailing average.

  • Mar 6, 2025

    Grew 87% QoQ, from 63 to 118 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nanogen Pharmaceutical Biotechnology JSC Filings

Explore SEC and related filing metadata, where available.

Nanogen Pharmaceutical Biotechnology JSC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nanogen Pharmaceutical Biotechnology JSC's valuation, stock price, and market status.

Is Nanogen Pharmaceutical Biotechnology JSC a public or private company?

Nanogen Pharmaceutical Biotechnology JSC is a private company.

What is the current stock price of Nanogen Pharmaceutical Biotechnology JSC?

Nanogen Pharmaceutical Biotechnology JSC is a private company, so its shares have no public market price. Caplight tracks Nanogen Pharmaceutical Biotechnology JSC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nanogen Pharmaceutical Biotechnology JSC worth (valuation)?

Nanogen Pharmaceutical Biotechnology JSC's valuation is estimated at $220.0M based on funding round data.

Can I buy Nanogen Pharmaceutical Biotechnology JSC stock?

Nanogen Pharmaceutical Biotechnology JSC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nanogen Pharmaceutical Biotechnology JSC's last funding round?

Nanogen Pharmaceutical Biotechnology JSC's most recent funding round was Private Equity on March 29, 2019.

Who are the main investors in Nanogen Pharmaceutical Biotechnology JSC?

Key investors in Nanogen Pharmaceutical Biotechnology JSC include KIS Vietnam Securities Corporation, Company K Partners, HB Investment, Kiwoom Investment, STIC Investments.

Will Nanogen Pharmaceutical Biotechnology JSC IPO soon?

No public IPO plans have been announced for Nanogen Pharmaceutical Biotechnology JSC.

How can I track Nanogen Pharmaceutical Biotechnology JSC secondary market activity?

Caplight tracks bids, offers, and trades in Nanogen Pharmaceutical Biotechnology JSC's shares on secondary markets.

Firmographic Details

HeadquartersHo Chi Minh City
Employee Range128
Year Founded1997
Last FundingMar 29, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?